Search Results - "Pokorna, P."

Source apportionment of size resolved particulate matter at a European air pollution hot spot by Pokorná, P., Hovorka, J., Klán, M., Hopke, P.K.

“…Positive Matrix Factorization—PMF was applied to hourly resolved elemental composition of fine (PM0.15–1.15) and coarse (PM1.15–10) aerosol particles to…”
Get full text

Wood combustion, a dominant source of winter aerosol in residential district in proximity to a large automobile factory in Central Europe by Hovorka, J., Pokorná, P., Hopke, P.K., Křůmal, K., Mikuška, P., Píšová, M.

“…Industries in close proximity to residential districts are a historical phenomenon of urban development frequently causing air quality problem in European…”
Get full text

Variability in Activation Properties in Relation to Meteorological Phenomena by Zíková, N., Pokorná, P., Makeš, O., Rotrekl, J., Sedlák, P., Pešice, P., Ždímal, V.

“…In situ campaigns focused on aerosol—cloud interactions were performed to describe the size-dependent activation of aerosols of various origins during variable…”
Get full text

Activation of atmospheric aerosols in fog and low clouds by Zíková, N., Pokorná, P., Makeš, O., Sedlák, P., Pešice, P., Ždímal, V.

“…Ground-based measurements of low stratus or fog at a mountain station in the Czech Republic have been conducted to describe the cloud nucleus activation…”
Get full text

The Impact of Hypothermia on the Pharmacokinetics of Drugs Used in Neonates and Young Infants by Pokorna, P, Wildschut, E D, Vobruba, V, van den Anker, John N, Tibboel, D

“…Therapeutic hypothermia (HT) is frequently used in neonates with hypoxic-ischemic encephalopathy and young infants during cardiopulmonary bypass (CPB)…”
Get more information

Particulate matter source apportionment in a village situated in industrial region of Central Europe by Pokorná, P., Hovorka, J., Kroužek, J., Hopke, P.K.

“…The bilinear receptor model positive matrix factorization (PMF) was used to apportion particulate matter with an aerodynamic diameter of 1-10 μm (PM 1-10 )…”
Get full text

A new methodology to assess the performance and uncertainty of source apportionment models II: The results of two European intercomparison exercises by Belis, C.A., Karagulian, F., Amato, F., Almeida, M., Artaxo, P., Beddows, D.C.S., Bernardoni, V., Bove, M.C., Carbone, S., Cesari, D., Contini, D., Cuccia, E., Diapouli, E., Eleftheriadis, K., Favez, O., El Haddad, I., Harrison, R.M., Hellebust, S., Hovorka, J., Jang, E., Jorquera, H., Kammermeier, T., Karl, M., Lucarelli, F., Mooibroek, D., Nava, S., Nøjgaard, J.K., Paatero, P., Pandolfi, M., Perrone, M.G., Petit, J.E., Pietrodangelo, A., Pokorná, P., Prati, P., Prevot, A.S.H., Quass, U., Querol, X., Saraga, D., Sciare, J., Sfetsos, A., Valli, G., Vecchi, R., Vestenius, M., Yubero, E., Hopke, P.K.

“…The performance and the uncertainty of receptor models (RMs) were assessed in intercomparison exercises employing real-world and synthetic input datasets. To…”
Get full text

Evaluation of receptor and chemical transport models for PM10 source apportionment by Belis, C.A., Pernigotti, D., Pirovano, G., Favez, O., Jaffrezo, J.L., Kuenen, J., Denier van Der Gon, H., Reizer, M., Riffault, V., Alleman, L.Y., Almeida, M., Amato, F., Angyal, A., Argyropoulos, G., Bande, S., Beslic, I., Besombes, J.-L., Bove, M.C., Brotto, P., Calori, G., Cesari, D., Colombi, C., Contini, D., De Gennaro, G., Di Gilio, A., Diapouli, E., El Haddad, I., Elbern, H., Eleftheriadis, K., Ferreira, J., Vivanco, M. Garcia, Gilardoni, S., Golly, B., Hellebust, S., Hopke, P.K., Izadmanesh, Y., Jorquera, H., Krajsek, K., Kranenburg, R., Lazzeri, P., Lenartz, F., Lucarelli, F., Maciejewska, K., Manders, A., Manousakas, M., Masiol, M., Mircea, M., Mooibroek, D., Nava, S., Oliveira, D., Paglione, M., Pandolfi, M., Perrone, M., Petralia, E., Pietrodangelo, A., Pillon, S., Pokorna, P., Prati, P., Salameh, D., Samara, C., Samek, L., Saraga, D., Sauvage, S., Schaap, M., Scotto, F., Sega, K., Siour, G., Tauler, R., Valli, G., Vecchi, R., Venturini, E., Vestenius, M., Waked, A., Yubero, E.

“…In this study, the performance of two types of source apportionment models was evaluated by assessing the results provided by 40 different groups in the…”
Get full text

Effect of co-medication on the pharmacokinetic parameters of phenobarbital in asphyxiated newborns by Šíma, M, Pokorná, P, Hronová, K, Slanař, O

“…Phenobarbital is an anticonvulsive drug widely used in newborns with hypoxic-ischemic encephalopathy. The objective of our study was to describe possible…”
Get full text

Pharmacotherapy in neonatal and pediatric extracorporeal membrane oxygenation (ECMO) by Wildschut, E D, Ahsman, M J, Houmes, R J, Pokorna, P, de Wildt, S N, Mathot, R A A, Tibboel, D

“…ECMO support is an established life saving therapy for potentially reversible respiratory and/or cardiac failure. Improvement of outcome depends on effective…”
Get more information

P-153Regorafenib in the real-life clinical practice: data from the czech registry by Buchler, T, Bortlicek, Z, Hejduk, K, Melichar, B, Pokorna, P, Linke, Z, Petruzelka, L, Finek, J, Prausova, J, Kubackova, K

Get full text

Activity time budget patterns of sheep and goats co-grazing on semi-natural species-rich dry grassland by Pokorná, P., Hejcmanová, P., Hejcman, M., Pavlů, V.

“…Activity time budget patterns and grazing response to sward and environmental conditions were investigated for paddocks of sheep and goats co-grazing for…”
Get full text

Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry by Kubackova, Katerina, Bortlicek, Z., Pavlik, T., Melichar, B., Linke, Z., Pokorna, P., Vyzula, R., Prausova, J., Buchler, T.

“…The aim of this study was to describe the characteristics and outcomes of a large cohort of patients treated with sorafenib in clinical practice and to…”
Get full text

Estimation of initial phenobarbital dosing in term neonates with moderate‐to‐severe hypoxic ischaemic encephalopathy following perinatal asphyxia by Šíma, M., Pokorná, P., Hartinger, J., Slanař, O.

“…Summary What is known and objective Phenobarbital is the first‐line treatment of seizures in asphyxiated neonates; however, due to the high pharmacokinetic…”
Get full text

Sufentanil and midazolam dosing and pharmacogenetic factors in pediatric analgosedation and withdrawal syndrome by Hronová, K, Pokorná, P, Posch, L, Slanař, O

“…Our aim was to describe the effect of dosing and genetic factors on sufentanil- and midazolam-induced analgosedation and withdrawal syndrome (WS) in pediatric…”
Get full text

TOXICITY OF TARGETED THERAPY WITH IMATINIB IN PATIENT WITH NIJMEGEN BREAKAGE SYNDROME AND T -LYMPHOBLASTIC LYMPHOMA/LEUKEMIA HARBORING ZBTB16-ABL1 FUSION by Krenova, Z., Pokorna, P., Noskova, K., Pastorcak, A., Hlavackova, E., Vasikova, A., Sterba, J.

Get full text

116 - TOXICITY OF TARGETED THERAPY WITH IMATINIB IN PATIENT WITH NIJMEGEN BREAKAGE SYNDROME AND T -LYMPHOBLASTIC LYMPHOMA/LEUKEMIA HARBORING ZBTB16-ABL1 FUSION by Krenova, Z., Pokorna, P., Noskova, K., Pastorcak, A., Hlavackova, E., Vasikova, A., Sterba, J.

Get full text

Abstract PD-045: PHENOBARBITAL PHARMACOKINETICS IN NEWBORNS TREATED FOR HYPOXIC ISCHEMIC ENCEPHALOPATHY UNDERGOING THERAPEUTIC HYPOTHERMIA by Pokorna, P., Michalickova, D., Voller, S., Tibboel, D., Krekels, E.

Get full text

OP067 [Pharmacology » Individualized patient care]: PAIN AND SEDATION MANAGEMENT AND MONITORING IN PEDIATRIC INTENSIVE CARE UNITS ACROSS EUROPE: AN ESPNIC SURVEY by Daverio, M., Borell, F. V., Ramelet, A., Sperotto, F., Pokorna, P., Brenner, S., Mondardini, M. C., Tibboel, D., Amigoni, A., Ista, E.

Get full text

Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper by Smits, Anne, Annaert, Pieter, Cavallaro, Giacomo, De Cock, Pieter A. J. G., Wildt, Saskia N., Kindblom, Jenny M., Lagler, Florian B., Moreno, Carmen, Pokorna, Paula, Schreuder, Michiel F., Standing, Joseph F., Turner, Mark A., Vitiello, Benedetto, Zhao, Wei, Weingberg, Annelie‐Martina, Willmann, Raffaella, Anker, John, Allegaert, Karel

“…Developmental pharmacology describes the impact of maturation on drug disposition (pharmacokinetics, PK) and drug effects (pharmacodynamics, PD) throughout the…”
Get full text